Parexel Names Jamie Macdonald as CEO, as Co-founder Josef von Rickenbach Retires
7 March 2018 - - Waltham, Massachusetts-based biopharmaceutical services specialist Parexel International Corp. has appointed Jamie Macdonald as chief executive officer (CEO) effective March 15, 2018, the company said.
Josef von Rickenbach, who co-founded the company, will retire from his daily CEO duties and continue as chairman of the board.
Macdonald led INC Research, now known as Syneos Health, for several years, first as CEO and most recently as vice chairman. 
Prior to this, he served as INC's chief operating officer. He has held several leadership positions in the biopharmaceutical services industry, including senior vice president and head of global project management at Quintiles, now known as IQVIA.
Parexel simplifies the transformation of scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. Parexel develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries.